Hummsa Biotech
PrivateLast Round
Seed
Jun 1, 2024
Total Funding Raised
$150,000
Company Overview
Hummsa Biotech is a biotechnology company that develops next-generation oral GLP-1 small-molecule therapies and diagnostics for metabolic diseases such as diabetes and obesity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hummsa Biotech Comparables
Compare Hummsa Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Structure Therapeutics | 74% | |
| Terns Pharmaceutical | 74% | |
| Roche Holding | 72% |
Hummsa Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 1, 2024 | ||||
| Accelerator | Mar 1, 2023 |
Key People
Founding team and executive leadership
Hummsa Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 100X.VC | Seed |
| Centre for Innovation and Entrepreneurship, IIIT Hyderabad (CIE) | Accelerator |
| International Institute of Information Technology, Hyderabad | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 1715% MoM, from 52 to 944.
- Jun 1, 2024
$150K round led by 100X.VC
Hummsa Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hummsa Biotech's valuation, stock price, and market status.
Is Hummsa Biotech a public or private company?
Hummsa Biotech is a private company.
What is the current stock price of Hummsa Biotech?
Hummsa Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Hummsa Biotech worth (valuation)?
Valuation information for Hummsa Biotech is not publicly available.
Can I buy Hummsa Biotech stock?
Hummsa Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hummsa Biotech's last funding round?
Hummsa Biotech's most recent funding round was Seed on June 1, 2024.
Who are the main investors in Hummsa Biotech?
Key investors in Hummsa Biotech include 100X.VC, Centre for Innovation and Entrepreneurship, IIIT Hyderabad (CIE).
Will Hummsa Biotech IPO soon?
No public IPO plans have been announced for Hummsa Biotech.
How can I track Hummsa Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hummsa Biotech's secondary market activity and sign up for updates.